Skip to content
FY'25FY'24FY'23FY'22
$7M-70.1%$23.38M-54.1%$50.93M+82.3%
$314.7M+6.8%$294.67M+128%$129.51M+44.6%$89.54M+54.0%
$63.32M+61.1%$39.3M+38.8%$28.31M+18.5%$23.9M+19.2%
$378.02M+13.2%$333.98M+112%$157.82M+39.1%$113.43M+45.0%
-$159.31M+51.3%-$326.98M-143%-$134.43M-115%-$62.5M-24.3%
$45.62M-13.1%$52.5M+145%$21.47M+458%$3.85M+660%
-$113.7M+58.6%-$274.48M-143%-$112.96M-92.6%-$58.66M-17.9%
-$1.31+61.0%-$3.36-70.6%-$1.97-37.8%-$1.43-1.4%
-$156.61M+51.8%-$324.59M-146%-$131.96M-118%-$60.4M-24.4%
-$159.31M+51.3%-$326.98M-143%-$134.43M-115%-$62.5M-24.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is IDEAYA Biosciences, Inc.'s revenue?
IDEAYA Biosciences, Inc. (IDYA) generated $232.3M in revenue over the trailing twelve months, up 5822.2% year over year.
Is IDEAYA Biosciences, Inc. profitable?
IDEAYA Biosciences, Inc. is not currently profitable: it reported a net loss of $140.1M over the trailing twelve months, a -3921.1% net margin.
What is IDEAYA Biosciences, Inc.'s earnings per share?
IDEAYA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-1.60.
Where does IDEAYA Biosciences, Inc.'s income statement data come from?
Every line is extracted from IDEAYA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.